Peptide biohacking: Unravelling the science behind the social media hype

Peptide injectables. “Wolverine stacks.” Peptide longevity protocols. In the UK, #peptidestacking, an unregulated wellbeing trend, is dominating social media searches, driving concerns that some people are purchasing peptides from an unregulated grey market.

But peptides aren’t new. They are part of our ancient biology. From insulin to oxytocin, long before aesthetic clinics and biohacking forums, your physiology was already fluent in communicating through peptide signalling. 

So why are they suddenly so controversial? Dr Jenna Macciochi explains the science behind the peptide biohacking wellbeing trend.

Peptides: What are they and why do we need them?

The body’s messenger system, peptides, are short chains of amino acids (the building blocks that make up protein) that have joined together. 

Many peptides enter the body through food. When proteins, like chicken, are digested, they are broken down into smaller fragments that can interact with the body’s signalling systems.

A simple way to understand amino acids and peptides and their role in the body is to think of amino acids as individual letters.  A peptide is a word.  A full paragraph is a full protein.  Those peptide “words” carry instructions that trigger responses - Increase this. Calm that. Repair here. Store energy. Release energy. Initiate inflammation. Resolve inflammation.

Many peptides are produced within the body, but we are also exposed to peptide fragments through digestion. When we consume protein-rich foods, they are broken down into smaller units, including bioactive peptides that can interact with the body’s signalling systems. Collagen is a key example of this.

The truth is, while peptides may feel like wellbeing's latest trend, they’re nothing new. Your body has long been using peptides from the beginning, supporting your biology, moment by moment.

• Insulin is a peptide that regulates blood glucose.

• Oxytocin is a peptide that shapes bonding and trust.

• Glucagon is a peptide that balances blood sugar.

• Antimicrobial peptides are produced in your skin and gut as part of the innate immune system.

Peptide biohacking: What is it and why is it so popular?

While the body naturally produces many peptides, these are not the peptides involved in the peptide biohacking wellbeing trend that’s rising in popularity.

Instead, peptide stacking or biohacking involves injecting two or more different types of synthetic peptides with the hope of achieving multiple benefits at once.

This may involve established medicines or pharmaceutical analogues designed to mimic natural peptides signalling molecules. It could also be experimental “research chemicals” circulating in a regulatory grey zone. 

Medical Peptides

Extensively studied, carefully dosed and regulated, these peptides are prescribed by medical professionals as a treatment for fertility issues, endocrinology and metabolic disease. A well-known example is insulin, a peptide hormone used to treat diabetes. 

Pharmaceutical peptide analogues

These are laboratory-engineered versions of naturally occurring peptides. They mimic or enhance signals that the body already produces, but may have been adapted to last longer or act more selectively. The popular weight-loss peptide GLP-1 is a great example. Naturally, it lasts minutes in the body. Pharmaceutical versions last for days.

Experimental or cosmetic injectable stacks

These are unlicensed and marketed online for purposes such as skin rejuvenation, faster injury recovery and longevity. Examples include:

• BPC-157 – promoted for tissue repair and gut healing

• Ipamorelin – marketed as a growth hormone secretagogue

• CJC-1295 – often combined with other secretagogues

• Melanotan II – used for tanning and sometimes libido enhancement

Biohacking or biological health risk: How safe is peptide stacking?

While the science surrounding peptide stacking is exciting, some others are urging caution.  Not least because in the UK, most experimental peptides are typically supported only by early-stage or limited human evidence and not licensed medicines under the MHRA- the government body responsible for regulating medicines for safe use. 

This means they cannot legally be marketed for human consumption unless authorised. Instead, they are supplied by private clinics and used outside regulated medical frameworks - worrying wellbeing experts.

Similarly, the USA’s medical regulatory body, the FDA, has not approved many of these peptides for human use. Yet still, they are sold online, labelled “for research use only.”

And that’s just part of the picture. Beyond regulation, there is a deeper biological point to consider.

Peptides may be precise messengers, but they operate within complex networks. For example, stimulating growth hormone pathways with peptides not only influences muscle. It can also affect insulin sensitivity, inflammatory tone, cellular proliferation and sleep architecture. Altering melanocortin pathways with peptides not only changes pigmentation. It can influence appetite, libido and central nervous system signalling.  

So when we artificially amplify one signal, we are rarely affecting just one outcome.

Biology is not linear. It’s networked.

While we can’t say for sure if any given injectable stacks are safe, in many cases, these compounds are moving from lab bench to consumer use faster than long-term human data can keep up.

Availability, in this case, does not equate to regulatory approval. That’s why it remains important to check the evidence and regulatory status behind any wellbeing treatment before considering it. 

Final thoughts: Supporting the Body’s Own Peptide Ecology

The cultural moment we are living in tends to reward intensity. Faster fat loss. Stronger muscle gain. Sharper cognition. Reversed ageing. 

Peptides are increasingly positioned as shortcuts to these outcomes. But while they might offer promise, biology rarely responds well to being hurried.

Peptide signalling does not exist in isolation. It depends on the biological terrain in which those signals operate. In other words, signalling works best when the system is stable.

Supporting your peptide ecology begins with the terrain:

• Supplying the raw materials through adequate, high-quality protein

• Nourishing signalling pathways with naturally occurring bioactive peptides, such as collagen

• Cultivating a diverse, nutrient-rich diet that supports gut integrity—one of the body’s most active signalling interfaces

• Regulating the nervous system, because chronic stress distorts how signals are received and interpreted

This is where the conversation becomes more interesting.

Not as a race to inject the latest compound, but as a deeper understanding of how your biology already communicates, and how to support it intelligently.

There is a difference between therapeutic necessity and optimisation appetite.

And perhaps the most important question is:

Are we stabilising the terrain before we amplify the signal?

Because the most powerful peptide system you will ever work with… is the one your body is already running.

References

Al Musaimi, O., Al-Khudhair, S., Alfadhel, M., et al. (2024) 'Exploring FDA-approved frontiers: insights into natural and synthetic peptides as novel drug targets and therapeutic agents', Biomolecules, 14(3), p. 264. doi:10.3390/biom14030264

Craft, E., Fujiyama, H. and Lukowiak, K. (2021) 'Role of insulin in health and disease: an update', International Journal of Molecular Sciences, 22(12), p. 6403. doi:10.3390/ijms22126403

Department of Health and Social Care (2023) UK‑wide licensing for human medicines. London: Medicines and Healthcare products Regulatory Agency (MHRA).
Available at: https://www.gov.uk/government/publications/uk-wide-licensing-for-human-medicines/uk-wide-licensing-for-human-medicines (Accessed: 1 April 2026).

Forbes Kaprive, J. and Krishnamurthy, K. (2023) ‘Biochemistry, Peptide’, StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK562260/ (Accessed: 1 April 2026).

Medicines and Healthcare products Regulatory Agency (2026) MHRA Safety Roundup: March 2026. London: MHRA. Available at: https://www.gov.uk/drug-device-alerts/mhra-safety-roundup-march-2026 (Accessed: 1 April 2026).

U.S. Food and Drug Administration (2026) FDA intends to take action against non‑FDA‑approved GLP‑1 drugs. Silver Spring, MD: FDA. Available at: https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs (Accessed: 1 April 2026).

Yamasaki, K. and Gallo, R.L. (2008) 'Antimicrobial peptides in human skin disease', European Journal of Dermatology, 18(1), pp. 11–21. doi:10.1684/ejd.2008.0304